| ABBOTT LABORATORIES |
| USA |
| Gesundheit |
| US0028241000 / 850103 |
| ABL (Frankfurt) / ABT (NYSE) |
| FRA:ABL, ETR:ABL, ABL:GR, NYSE:ABT |
| S&P500 |
| https://www.abbott.com/ |
|
Abbott Laboratories is a global healthcare company that develops and markets a broad portfolio of medical devices, diagnostics, nutritional products, and branded generic medicines. Its current business is organized around four core segments: Medical ..
>Volltext.. |
| 169100.45 Mio. EUR |
| 193313.28 Mio. EUR |
| 39885.1 Mio. EUR |
| 9508.72 Mio. EUR |
| 4627.65 Mio. EUR |
| 2.66 EUR |
| 27918.29 Mio. EUR |
| 4369.94 Mio. EUR |
| 8480.45 Mio. EUR |
| 0.31 |
| 11.46% |
| -59.99% |
| 2.13 EUR |
| 2.17% |
| 2.17% |
| 15.07.26 - 0.550431€ 15.04.26 - 0.53442895€ >weitere anzeigen... |
| ABBOTT LABORATORIES, ABBOTT LABS, ABBOTT LAB, (ABT), ABT |
| 23.08.26 |